Jefferies Group's XFOR Position Overview
Jefferies Group (via Jefferies Financial Group Inc.) currently holds 19,474 shares of X4 Pharmaceuticals, Inc. (XFOR) worth $80,428, representing 0.00% of the portfolio. First purchased in 2025-Q4, this recently established position has been held for 2 quarters.
Based on recent 13F filings, Jefferies Group has initiated a new position in XFOR, representing a fresh investment thesis on this company. Largest reduction occurred in Q1 2026, reducing 6,644 shares.
Analysis based on 13F filings available since 2013 Q2
Jefferies Group's X4 Pharmaceuticals (XFOR) Holding Value Over Time
Track share changes against reported price movement
Quarterly X4 Pharmaceuticals (XFOR) Trades by Jefferies Group
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | -6,644 | Reduce 25.44% | 19,474 | $4.13 |
| Q4 2025 | +26,118 | New Buy | 26,118 | $4.00 |
Jefferies Group's X4 Pharmaceuticals Investment FAQs
Jefferies Group first purchased X4 Pharmaceuticals, Inc. (XFOR) in Q4 2025, acquiring 26,118 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Jefferies Group has held X4 Pharmaceuticals, Inc. (XFOR) for 2 quarters since Q4 2025.
Jefferies Group's largest addition to X4 Pharmaceuticals, Inc. (XFOR) was in Q4 2025, adding 26,118 shares worth $104,472.
According to the latest 13F filing for Q1 2026, Jefferies Group's firm, Jefferies Financial Group Inc., owns 19,474 shares of X4 Pharmaceuticals, Inc. (XFOR), valued at approximately $80,428.
As of the Q1 2026 filing, X4 Pharmaceuticals, Inc. (XFOR) represents approximately 0.00% of Jefferies Group's publicly disclosed stock portfolio, making it one of their key holdings.
Jefferies Group's peak holding in X4 Pharmaceuticals, Inc. (XFOR) was 26,118 shares, as reported at the end of Q4 2025.